Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
Become a Member | Sign in
Home>Products>This Product

SpectraMax L Luminescence Microplate Reader

Product Description
Designed for maximum detection sensitivity, the SpectraMax¬ģ L Microplate Reader limits the crosstalk between samples with an internal aperture for use with standard 96- and 384-well microplates. In conjunction with ultra-fast photon counting technology, the SpectraMax L Reader delivers a superior signal-to-noise ratio for luminescence. Extended over 9 orders of magnitude, the dynamic range of simultaneous photon counting and analog detection allows for capturing luminescence from dim samples while helping to avoid saturation from brighter samples that is unmatched by other microplate readers.

The SpectraMax L Microplate Reader is an upgradeable platform that can be added to over time, available with one or more luminescence detectors, enabling higher throughput configurations compared to single detector microplate readers. Optional injectors offer the capability to perform fast flash assays in addition to the more stable glow assays. These next generation injectors have a significantly extended lifetime over traditional syringe injectors. The precise dual injectors and detection sensitivity make the SpectraMax L Reader ideal for widely used dual luciferase reporter gene assays and carries the Promega DLReady certification.
Product SpectraMax L Luminescence Microplate Reader
Company Molecular Devices Product Directory
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Molecular Devices Product Directory
1311 Orleans Drive Sunnyvale, CA 94089-11361 United States

Tel: 1-800-635-5577
Fax: 1-408-548-6439

Scientific News
Mathematical Model Forecasts the Path of Breast Cancer
Chances of survival depend on which organs breast cancer tumors colonize first.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Biomedical Imaging at One-Thousandth the Cost
Mathematical modeling enables $100 depth sensor to approximate the measurements of a $100,000 piece of lab equipment.
Improving Outcomes for Lung Cancer and Diabetic Patients
Novel technologies have been developed with support from SBRI Healthcare funding.
New Way of Detecting Cancer
A new RNA test of blood platelets can be used to detect, classify and pinpoint the location of cancer by analysing a sample equivalent to one drop of blood.
Rapid, Portable Ebola Diagnostic
Scientists confirmed the efficiency of the novel Ebola detection method in field trials.
New, Better Test for Prostate Cancer
A study from Karolinska Institutet shows that a new test for prostate cancer is better at detecting aggressive cancer than PSA.
Blood Test Picks Out Prostate Cancer Drug Resistance
Scientists have developed a blood test that can identify key mutations driving resistance to a widely used prostate cancer drug, and identify in advance patients who will not respond to treatment.
Antibody Targets Key Cancer Marker
University of Wisconsin-Madison researchers have created a molecular structure that attaches to a molecule on highly aggressive brain cancer and causes tumors to light up in a scanning machine.
Key Piece of MRSA Vaccine Puzzle
New research funded by the Health Research Board and the Wellcome Trust has pinpointed immune cells that could be targeted by an MRSA vaccine.

Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos